Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First, is scheduled to end on July 31st. Learn about your options to continue receiving care at Temple Health.
Prostate Cancer Screening Guidelines Puts Patient Choice First
Current U.S. Preventive Services Task Force (USPSTF) recommendations state that men ages 55 to 69 should decide for themselves whether to undergo a prostate-specific antigen (PSA) test after discussing the potential benefits and harms with their doctor. ...
Read More![Link to](/sites/default/files/styles/card/public/PSAtest.jpg?h=79dabc76&itok=-FPntiPL)
Prostate Cancer Screening Guidelines Puts Patient Choice First
Prostate Cancer Survivors: This Blog Is For You
Urinary incontinence is a possible side effect of many cancer treatments. It’s especially problematic for men who’ve had prostate cancer. Although it may seem like a touchy topic, there’s no room for embarrassment or shame if you’re a prostate cancer sur...
Read More![Link to](/sites/default/files/styles/card/public/pelvicfloormen.jpg?h=585cecb8&itok=9uV67qWg)
Prostate Cancer Survivors: This Blog Is For You
The Good News About Radiation Treatments and Your Skin
Many people think skin problems go hand-in-hand with radiation treatments for cancer. But that’s not always the case anymore. “Basically, most things we do now don’t impact the skin at all” said Eric M. Horwitz, MD, FABS, FASTRO, Chair of Radiation Oncol...
Read More![Link to](/sites/default/files/styles/card/public/radiation-therapy-and-skin-sensitivity1.png?h=2240b8e9&itok=RMMUOSJ0)
The Good News About Radiation Treatments and Your Skin
Cryosurgery's Clinical Benefit: Delays Needed for Hormone Therapy for Most Men with Locally Recurrent Prostate Cancer
A recent Fox Chase Cancer Center study showed that 80 percent of men who have cryoablation surgery for recurrent prostate cancer can safely delay the start of androgen deprivation therapy (ADT) for two or more years and, as a result, avoid the risk of cardi...
Read More![Link to](/sites/default/files/styles/card/public/drchen.jpg?h=6db3772d&itok=t0vgLi-l)
Cryosurgery's Clinical Benefit: Delays Needed for Hormone Therapy for Most Men with Locally Recurrent Prostate Cancer
Spring 2018 AUA & SUO Presentations
Two Fox Chase Cancer Center urologic oncologists participated in presentations at the spring 2018 annual meeting of the American Urological Association (AUA) and the Society for Urologic Oncology (SUO). Rosalia Viterbo, MD, FACS, brought her extensive ex...
Read More![Link to](/sites/default/files/styles/card/public/AUA.FINAL_.jpg?h=75728139&itok=rOtRML4M)
Spring 2018 AUA & SUO Presentations
Prostate Cancer: The Gleason Score Explained
How aggressive is my prostate cancer? Is it growing slowly or quickly? If you’ve been diagnosed with prostate cancer—and this year alone nearly 165,000 men nationwide will be—these may be among the first questions you’ll ask your doctor. And the answers ...
Read More![Link to](/sites/default/files/styles/card/public/gleasonscoregraphic_1.gif?h=c5c2197a&itok=22tdHDh3)
Prostate Cancer: The Gleason Score Explained
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this